Retraction: Modulation of signal proteins: A plausible mechanism to explain how a potentized drug secale cor 30C diluted beyond Avogadro's limit combats skin papilloma in mice (Evidence-Based Complementary and Alternative Medicine (2011) 2011 (286320) DOI: 10.1093/ecam/nep084);Modulation of signal proteins: A plausible mechanism to explain how a potentized drug secale cor 30c diluted beyond Avogadro's limit combats skin papilloma in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Khuda Bukhsh, Anisur Rahman ^a   Bhattacharyya, Soumya Sundar ^a   Paul, Saili ^a   Dutta, Suman ^a   Boujedaini, Naoual ^b   Belon, Philippe ^b  

^a UNIVERSITY OF KALYANI   (India)

^b Boiron Laboratory   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CROTON OIL; CYTOCHROME C; DIMETHYLBENZ[A]ANTHRACENE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOPROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE B; PROTEIN P53; PROTEINASE; SECALE CORNUTUM 30; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; COMET ASSAY; CONTROLLED STUDY; CYTOGENETICS; DILUTION; DNA DAMAGE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTOXICITY; HISTOLOGY; HOMEOPATHY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RYE; SKIN PAPILLOMA;

EID: 80052764910     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2021/2108674     Document Type: Erratum

References (41)

1. Jonas W. B., Gaddipati J. P., Rajeskhum N. V., Sharma A., Thangapazham R. L., Warren J., Can homeopathic treatment slow prostate cancer growth? Integrative Cancer Therapies 2006 5 343 349 (Pubitemid 44721990)
2. Biswas S. J., Khuda-Bukhsh A. R., Effect of homeopathic drug, Chelidonium, an amelioration of p-DAB induced hepatocarcinogenesis in mice BMC Complementary and Alternative Medicine 2002 2, article 4
3. Biswas S. J., Khuda-Bukhsh A. R., Evaluation of protective potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice Indian Journal of Experimental Biology 2004 42 7 698 714 (Pubitemid 38889462)
4. Pathak S., Das J. K., Biswas S. J., Khuda-Bukhsh A. R., Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice Molecular and Cellular Biochemistry 2006 285 121 131
5. Pathak S., Bhattacharjee N., Das J. K., Choudhury S. C., Roy-Karmakar S., Banerjee P., Supportive evidences for anti-cancerous potential of an alternative medicine in hepatocarcinogenesis of mice Forsch Komplementarmed 2007 14 148 156 (Pubitemid 47013382)
6. Sunila E. S., Kuttan R., Preethi K. C., Kuttan G., Dynamized preparations in cell culture Evidence-Based Complementary and Alternative Medicine 2009 6 2 257 263
7. Es S., Kuttan G., Kc P., Kuttan R., Effect of homeopathic medicines on transplanted tumors in mice Asian Pacific Journal of Cancer Prevention 2007 8 3 390 394
8. Shang A., Huwiter-Muntener K., Nartey L., Juni P., Dorig S., Sterne J. A., Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy Lancet 2005 366 726 732 (Pubitemid 41207234)
9. Moffett J. R., Arun P., Namboodiri M. A., Laboratory research in homeopathy: con Integrative Cancer Therapies 2006 5 4 333 342
10. Khuda-Bukhsh A. R., Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo Complementary Therapies in Medicine 1997 5 43 46
11. Khuda-Bukhsh A. R., Towards understanding molecular mechanisms of action of homeopathic drugs: an overview Molecular and Cellular Biochemistry 2003 253 1-2 339 345 (Pubitemid 37321741)
12. Khuda-Bukhsh A. R., Laboratory research in homeopathy Integrative Cancer Therapies 2006 5 1 14
13. Bellavite P., Contorti A., Dontarllo F., Ortolani R., Immunology and Homeopathy: 2. Cells of the immune system and inflammation Evidence-Based Complementary and Alternative Medicine 2006 3 13 24 (Pubitemid 43999647)
14. Currier N., Solomon S. E., Demicco E. G., Chang D. L. F., Farago M., Ying H., Dominguez I., Sonenshein G. E., Cardiff R. D., Xiao Z.-X. J., Sherr D. H., Seldin D. C., Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors Toxicologic Pathology 2005 33 6 726 737 (Pubitemid 43154600)
15. Bhattacharyya S. S., Mandal S. K., Biswas R., Paul S., Pathak S., Boujaedaini N., In vitro studies demonstrate anticancer activity of an alkaloid of plant Gelsemium semipervirens Experimental Biology and Medicine 2008 233 1591 1601
16. Peng B., Hu Q., Liu X., Wang L., Chang Q., Li J., Duchesnea phenolic fraction inhibits in vitro and in vivo growth of cervical cancer through induction of apoptosis and cell cycle arrest Experimental Biology and Medicine 2009 234 74 83
17. Boericke W., Pocket Manual of Homeopathic Materia Medica. Indian Edition 1976 Calcutta, India Sett Dey and Co.
18. Trombino A. F., Near R. I., Matulka R. A., Yang S., Hafer L. J., Toselli P. A., Kim D. W., Rogers A. E., Sonenshein G. E., Sherr D. H., Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis Breast Cancer Research and Treatment 2000 63 2 117 131
19. MacDonald C. J., Ciolino H. P., Yeh G. C., The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin Cancer Research 2004 64 1 429 434 (Pubitemid 38114128)
20. Singhal R., Badger T. M., Ronis M. J., Reduction in 7,12-dimethylbenz[a] anthracene-induced hepatic cytochrome-P450 1A1 expression following soy consumption in female rats is mediated by degradation of the aryl hydrocarbon receptor Journal of Nutrition 2007 137 1 19 24 (Pubitemid 46052853)
21. Motiwale L., Ingle A. D., Rao K. V. K., Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression Cancer Letters 2005 223 1 27 35 (Pubitemid 40703921)
22. Jung K. J., Wallig M. A., Singletary K. W., Purple grape juice inhibits 7,12-dimethylbenz[a]antracene(DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation Cancer Letters 2006 233 279 288 (Pubitemid 43327384)
23. Roomi M. W., Roomi N. W., Kalinovsky T., Ivanov V., Rath M., Niedzwiecki A., Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture Medical Oncology 2008 25 3 333 340
24. Das R. K., Hossain Sk U., Bhattacharya S., Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation Cancer Letters 2005 230 90 101 (Pubitemid 41506964)
25. Bhattacharyya S. S., Paul S., Mandal S. K., Banerjee A., Boujedaini N., Khuda-Bukhsh A. R., A synthetic coumarin (4-Methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice European Journal of Pharmacology 2009 614 13 128 136
26. Arabzadeh A., Troy T.-C., Turksen K., Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis BMC Cancer 2007 7, article no. 196
27. Burnette W. N., Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A Analytical Biochemistry 1981 112 195 203
28. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with Folin-Phenol reagent The Journal of Biological Chemistry 1951 193 265 275
29. Wyrobek A. J., Watchmaker G., Gordon L., Kilbey B. J., Legator M., Nichols W., Ramel C., Hand-book of mutagenecity testing protocols Hand-Book of Mutagenecity Test Procedures 1983 Amsterdam, The Netherlands Elsevier 733 750
30. Wojewodza M., Kruszewski M., Inwanenko T., Collins A. R., Szumiel I., Application of the comet assay for monitoring DNA damage in workers exposed to chronic low dose irradiation I. Total damage Mutation Research 1998 416 21 35 (Pubitemid 28398844)
31. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining flow cytometry Journal of Immunological Methods 1991 139 271 279
32. Dhawan D., Balasubramanian S., Amonkar A. J., Singh N., Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis Carcinogenesis 1999 20 6 997 1003 (Pubitemid 29263742)
33. Christou M., Savas., Spink D. C., Gierthy J. F., Jefcoate C. R., Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachloro-dibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells Carcinogenesis 1994 15 4 725 732 (Pubitemid 24124419)
34. Reyes H., Reisz-Porszasz S., Hankinson O., Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor Science 1992 256 5060 1193 1195
35. Reisz-Porszasz S., Probst M. R., Fukunaga B. N., Hankinson O., Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT) Molecular and Cellular Biology 1994 14 9 6075 6086 (Pubitemid 24264437)
36. Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., Funae Y., Fujii-Kuriyama Y., cDNA cloning and structure of mouse putative Ah receptor Biochemical and Biophysical Research Communications 1992 184 1 246 253
37. Coumailleau P., Poellinger L., Gustaffsson J. A., Whitelaw M. L., Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity The Journal of Biological Chemistry 1995 270 25291 25300
38. Kumar M. B., Ramadoss P., Reen R. K., Vanden Heuvel J. P., Perdew G. H., The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin mediated transcriptional activity Journal of Biological Chemistry 2001 276 45 42302 42310
39. Basu P., Jones L., Carpenter J., Effect of adsorption onto glass nanoparticles on protein structure The AAPS Journal 2006 8 s2
40. Doliviera de Oliveira C. C., de Oliveira S. M., Goes V. M., Probst C. M., Krieger M. A., Buchi Dde F., Gene expression profiling of macrophages following mice treatment with an immunomodulator medication Journal of Cellular Biochemistry 2008 104 1364 1377 (Pubitemid 351961707)
41. Khuda-Bukhsh A. R., Pathak S., Homeopathic drug discovery: theory update and methodological aspect Expert Opinion on Drug Discovery 2008 3 8 979 990